VISEN Pharmaceuticals(HK:2561)
HK$12.15-0.73 (-5.67%)
HK:2561
VISEN Pharmaceuticals Revenue
HK$12.15
At close:-0.73 (-5.67%)
Want to see HK:2561 full AI Analyst Report?
VISEN Pharmaceuticals (2561) Revenue
0 Followers
VISEN Pharmaceuticals Revenue
VISEN Pharmaceuticals had a revenue of 10.58M in the quarter ending Jun 30, 2026, with 0.00%. This bring the company's revenue in the last twelve months to 20.40M, Increased 128.08%. In the fiscal year ending Dec 31, 2025, VISEN Pharmaceuticals had annual revenue of 160.73K with -94.21% growth.
- Revenue (ttm)
- 20.40M
- Revenue Growth
- ―
- P/S Ratio
- 9129.52
- Revenue/Employee
- HKD 1,960
- Employees
- 82
- Market Cap
- HKD 1.47B
Revenue Chart
VISEN Pharmaceuticals Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 160.73K | -2.62M | -94.21% |
| Dec 31, 2024 | 2.78M | 4.45M | -266.39% |
| Dec 31, 2023 | -1.67M | -1.67M | ― |
| Dec 31, 2022 | 0.00 | 0.00 | ― |
| Dec 31, 2021 | 0.00 | 0.00 | ― |
| Dec 31, 2020 | 0.00 | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.